Maternal Murine Cytomegalovirus Infection during Pregnancy Up-regulates the Gene Expression of Toll-like Receptor 2 and 4 in Placenta

Abstract

Increasing evidence has revealed that maternal cytomegalovirus (CMV) infection may be associated with neurodevelopmental disorders in offspring. Potential relevance between the placental inflammation and CMV-related autism has been reported by clinical observation. Meanwhile, abnormal expression of Toll-like receptor 2 (TLR2) and TLR4 in placenta of patients with chorioamnionitis was observed in multiple studies. IL-6 and IL-10 are two important maternal inflammatory mediators involved in neurodevelopmental disorders. To investigate whether murine CMV (MCMV) infection causes alterations in placental IL-6/10 and TLR2/4 levels, we analyzed the dynamic changes in gene expression of TLR2/4 and IL-6/10 in placentas following acute MCMV infection. Mouse model of acute MCMV infection during pregnancy was created, and pre-pregnant MCMV infected, lipopolysaccharide (LPS)-treated and uninfected mice were used as controls. At E13.5, E14.5 and E18.5, placentas and fetal brains were harvested and mRNA expression levels of placental TLR2/4 and IL-6/10 were analyzed. The results showed that after acute MCMV infection, the expression levels of placental TLR2/4 and IL-6 were elevated at E13.5, accompanied by obvious placental inflammation and reduction of placenta and fetal brain weights. However, LPS 50 μg/kg could decrease the EL-6 expression at E13.5 and E14.5. This suggests that acute MCMV infection during pregnancy could up-regulate the gene expression of TLR2/4 in placental trophoblasts and activate them to produce more proinflammatory cytokine IL-6. High dose of LPS stimulation (50 μg/kg) during pregnancy can lead to down-regulation of IL-6 levels in the late stage. Imbalance of IL-6 expression in placenta might be associated with the neurodevelopmental disorders in progeny.

Keywords

murine cytomegalovirus / maternal immune activation / placenta / TLR2 / TLR4 / IL-6

References

[1] AtladottirHO, ThorsenP, OstergaardL, et al.. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord, 2010, 40(12): 1423-1430

[2] BrownAS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. DevNeurobiol, 2012, 72(10): 1272-1276

[3] MatelskiL, Van de WaterJ. Risk factors in autism: Thinking outside the brain. J Autoimmun, 2016, 67: 1-7

[4] ZuckermanL, RehaviM, NachmanR, et al.. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology, 2003, 28(10): 1778-1789

[5] KnueselI, ChichaL, BritschgiM, et al.. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol, 2014, 10(11): 643-660

[6] OrnoyA, Weinstein-FudimL, ErgazZ. Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD). Front Neurosci, 2016, 10: 316

[7] SolekCM, FarooqiN, VerlyM, et al.. Maternal immune activation in neurodevelopmental disorders. Dev Dyn, 2018, 247(4): 588-619

[8] EstesML, McAllisterAK. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci, 2015, 16(8): 469-486

[9] MarquesAH, O’ConnorTG, RothC, et al.. The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders. Front Neurosci, 2013, 7: 120

[10] KitajimaJ, InoueH, OhgaS, et al.. Differential transmission and postnatal outcomes in triplets with intrauterine cytomegalovirus infection. Pediatr Dev Pathol, 2012, 15(2): 151-155

[11] KogaK, IzumiG, МогG, et al.. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications. Am J Reprod Immunol, 2014, 72(2): 192-205

[12] KumazakiK, NakayamaM, YanagiharaI, et al.. Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Hum Pathol, 2004, 35(1): 47-54

[13] RindsjoE, HolmlundU, Sverremark-EkstromE, et al.. Toll-like receptor-2 expression in normal and pathologic human placenta. Hum Pathol, 2007, 38(3): 468-473

[14] OrnoyA, Weinstein-FudimL, ErgazZ. Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol, 2015, 56: 155-169

[15] KhanD, FernandoP, CicvaricA, et al.. Longterm effects of maternal immune activation on depression-like behavior in the mouse. Transi Psychiatry, 2014

[16] SchmittgenTD, LivakKJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc, 2008, 3(6): 1101-1108

[17] EstesML, McAllisterAK. Maternal immune activation: Implications for neuropsychiatrie disorders. Science, 2016, 353(6301): 772-777

[18] YamashitaY, FujimotoC, NakajimaE, et al.. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord, 2003, 33(4): 455-459

[19] DoganY, YukselA, KaleliogluIH, et al.. Intracranial ultrasound abnormalities and fetal cytomegalovirus infection: report of 8 cases and review of the literature. Fetal Diagn Ther, 2011, 30(2): 141-149

[20] CannonMJ, SchmidDS, HydeTB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Wol, 2010, 20(4): 202-213

[21] LiuXL, ShuSN, WangH, et al.. Study of the viral titer and genetic expression in mice with murine cytomegalovirus infection. J Clin Pediatr, 2011, 4(29): 363-366

[22] SmithSE, LiJ, GarbettK, et al.. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci, 2007, 27(40): 10 695-10 702

[23] ChoiGB, YimYS, WongH, et al.. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science, 2016, 351(6276): 933-939

[24] MeitzerA, Van de WaterJ. The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology, 2017, 42(1): 284-298

[25] CareagaM, MuraiT, BaumanMD. Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates. Biol Psychiatry, 2017, 81(5): 391-401

[26] GayleDA, BelooseskyR, DesaiM, et al.. Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol, 2004R1024-1029

[27] AshdownH, DumontY, NgM, et al.. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry, 2006

[28] BelooseskyR, GayleDA, AmidiF, et al.. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol, 2006, 194(1): 268-273

[29] HolmlundU, CebersG, DahlforsAR, et al.. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology, 2002, 107(1): 145-151